China Contract Research Organization (CRO) Industry Report, 2012-2013

Publisher Name :
Date: 1-Feb-2013
No. of pages: 65
Inquire Before Buying

Compared to Europe and America, China developed pharmaceutical CRO industry 40 years later, with domestic industrial players amounting to over 500, most of which are SMEs. In general, Chinese CRO market scale occupies only 7%-10% of the world’s total, and in 2011-2012 the CRO market size of China approximated RMB22-28 billion.

Considering huge potentials of Chinese phramceutical market, intensive talent resource, relatively low cost and rich spectrum of diseases, foreign enterprises are accelerating to expand CRO market there. Presently, world-renowned CRO companies including Quintiles, Covance, PPD, CRL and ICON have set foot in China by building new establishments and M&As. In China, homegrown leaders cover WuXi AppTec Co., Ltd., Shanghai-headquartered ShangPharma Corporation, and Hangzhou Tigermed Consulting, with the respective revenue in Jan.-Sep., 2012 hitting USD374 million, USD94.47 million and USD29.84 million, the combined proportion of 14% in China CRO market.

In an aim to realize resource sharing and improve overall competitiveness, some domestic pharmaceutical CRO enterprises seek joint development by setting up alliance. A case in point is ABO, which was established in 2005 merging nine research institutes including Academy of Military Medical Sciences, National Institutes for Food and Drug Control, and National Center of Biomedical Analysis, gathering three national engineering centers and seven national engineering technology centers, with sharable hi-tech resources valuing RMB1 billion. In 2012, ABO had 38 corporate members (including Sino Biological Inc. and Pharmaron), with the total area newly increasing by 40,000 sq meters to 270,000 sq meters or more and the total revenue growing by 28.6% year-on-year to over RMB1.8 billion which accounted for 6.4% in Beijing biomedical R&D service industry. And the revenue generated by international orders rose by 14.7% YoY to RMB780 million.

In Jan. 2013, JOINN Laboratories (Beijing), a member of ABO, took over the San Francisco-based R&D and production bases of Bayer, opening a new chapter for Chinese biomedical enterprises’ acquisition of worldwide R&D bases transnational businesses in overseas countries. And JOINN Laboratories is scheduled to lavish USD100 million to set up a 300-mu(1mu=666.7sq meters)US-based Join Innovation Park, in an attempt to provide business incubator, technical support, international cooperation and other services for small-and medium-sized biomedical innovative enterprises in Silicon Valley and China.

The report highlights the followings:

  • international market, domestic macro- environment and polices, laws and regulations of China CRO industry;
  • status quo, market scale, competition pattern and development prediction of China CRO industry;
  • Operation, CRO business and development dynamics in China of six foreign and five domestic industrial players.

China Contract Research Organization (CRO) Industry Report, 2012-2013

Table of Contents

1. Overview of CRO Industry
1.1 Definition & Classification
1.2 Industry Background

2. Development Environment of CRO Industry in China
2.1 International Environment
2.2 Industry Environment
2.3 Policy Environment

3. Market Analysis of CRO Industry in China
3.1 Status Quo
3.2 Market Size
3.3 Competition Pattern
3.4 Regional Market
3.4.1 Beijing
3.4.2Shanghai
3.4.3 Chengdu
3.5 Prospects

4.Key CRO Enterprises Worldwide
4.1 Covance Inc.
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Business in China
4.2 PAREXEL International
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Business in China
4.3 PPD
4.3.1 Profile
4.3.2 Operation
4.3.3 Business in China
4.4 Quintiles Transnational Corp.
4.4.1 Profile
4.4.2 Business in China
4.5 Charles River Laboratories International, Inc.
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Business in China
4.6 Asymchem Inc.
4.6.1 Profile
4.6.2 Business in China

5.Key CRO Enterprises in China
5.1 WuXi AppTec Co., Ltd.
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Development Trend and Prospects
5.2 ShangPharma Corporation
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Development Trend and Prospects
5.3 Venturepharm Laboratories Ltd.
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Development Trend and Prospects
5.4 Tigermed Consulting Co., Ltd
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 Clients and Suppliers
5.4.6 Development Trend and Prospects
5.5 Sundia MediTech Co., Ltd."

List of Charts

Classification of CRO
Global CRO Market Size and Growth Rate, 2007-2012
Global Key CRO Organizations and Their Business
Total Industrial Sales and Growth Rate of China’s Pharmaceutical Manufacturing, 2008-2012
Total Industrial Sales of China’s Bio-chemical Pharmaceutical Manufacturing, 2008-2012
Chinese CRO Market Size and Growth Rate, 2007-2012
Classification of Chinese CRO Companies (by Business)
Key M&A Cases of CRO Industry in China, 2007-2011
Regional Distribution of Leading Foreign CROs in China
Revenue and YoY Growth Rate of ABO, 2010-2012
Sponsors of CRO in Zhonguancun (Listed in No Particular Order)
Platform Edge of Shanghai Pharma Engine
Major CRO Enterprises of Shanghai Pharma Engine
Revenue and Operating Profit of Covance, 2009-2012
Revenue of Covance by Business, 2010-2012
Revenue and Operating Profit of PAREXEL, 2009-2012
Revenue of PAREXEL by Business, 2009-2012
Revenue of PAREXEL by Region Worldwide, 2009-2012
Revenue of PPD, 2007-2010
Corporate Advantages of Excel PharmaStudies, Inc.
Revenue and Operating Profit of CRL, 2009-2012
Revenue Breakdown of CRL by Business, 2009-2012
Asymchem Inc’s Companies and Main Businesses in China
Operation of Asymchem Inc.(Tianjin), 2008 & Jan.2009-May, 2009
Branch Distribution of WuXi AppTec Co., Ltd
Revenue and Gross Margin of WuXi AppTec Co., Ltd, 2008-2012
Main Businesses of WuXi AppTec Co., Ltd
Revenue of WuXi AppTec Co., Ltd by Business, 2010-2012
Big Events of WuXi AppTec Co., Ltd, 2011-2012
Revenue and Gross Margin of WuXi AppTec Co., Ltd, 2011-2015E
Distribution of Subsidiaries of ShangPharma Corporation
Four R&D Bases of ShangPharma Corporation
Revenue and Gross Profit of ShangPharma Corporation, 2008-2012
Revenue Breakdown of ShangPharma Corporation by Business, 2009-2011
Shareholding (Joint-stock) Companies of Venturepharm Laboratories Ltd
Revenue and Gross Profit of Venturepharm Laboratories Ltd, 2007-2011
Revenue of Venturepharm Laboratories Ltd by Business, 2010-2011
Number of Cases of Venturepharm laboratories Approved by SFDA, 2002-2011
Seven Subsidiaries and Business Distribution of Tigermed Consulting Co., Ltd
Domestic and Foregin Customer Distribution of Tigermed by Region
Revenue and Profit of Tigermed, 2009-2012
New Contract Value and Average Contract Value of New Contracts of Tigermed, 2009-2011
New Contract Number and Value of Tigermed by Business, 2009-2011
Operating Revenue and Operating Cost of Tigermed by Business, 2009-2011
Revenue Breakdown of Tigermed by Region, 2009-2011
Revenue and Proportion from Clinical Test Technical Service Business of Tigermed, 2009-2011
Consolidated Gross Margin of Tigermed, 2009-2011
Gross Margin of Tigermed by Business, 2009-2011
Name List and Revenue Contribution of Tigermed’s Top 5 Clients, 2009-2011
Name list and Procurement of Tigermed’s Top 5 Suppliers,2009-2011
Number of Clinical Research Projects of Tigermed by Business
Clinical Research Projects of Tigermed by Disease
IPO Investment Projects of Tigermed
Business Layout of Tigermed after Production of Fundraising Projects

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma
    Published: 29-Oct-2014        Price: US $6995 Onwards        
    Large Degree of Innovation in NSCLC Pipeline The NSCLC pipeline currently has 389 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market comprises primarily ineffective chemotherapies that target tubulin or DNA replication, the pipeline shows an incredibly diverse range of therapies targeting multiple signaling pathways and molecules integral to cancer development. Thi......
  • Global Biologic Therapeutics Market 2014-2018
    Published: 29-Oct-2014        Price: US $3500 Onwards        Pages: 185
    Biologic therapeutics include virus, therapeutic serum, toxin, allergenic product, antitoxin, blood component or derivative, vaccine, blood, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), intended for the prevention, treatment, or cure of a disease or condition. These products differ from small molecules in terms of molecular weight, structure, synthesis, and immunogen......
  • Global Pharmaceutical Packaging Market 2014-2018
    Published: 29-Oct-2014        Price: US $2500 Onwards        Pages: 77
    A pharmaceutical product is any chemical substance formulated or compounded as a single active ingredient. The packaging of medicines is a very complex process, and because of its molecular and chemical structure, it needs to be packed in an extremely durable material so that it could reach the customer in a desirable condition. The evolution of new diseases and increased health awareness have brought a transformation in the Pharmaceutical Packaging market. The vendors in the Global Pharmaceutic......
  • 2014 Deep Research Report on Global and China Nalbuphine HCL Industry
    Published: 28-Oct-2014        Price: US $2200 Onwards        Pages: 121
    This is a professional and depth research report on Global and China Nalbuphine HCL industry. The report firstly introduced Nalbuphine HCL basic information included Nalbuphine HCL definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Nalbuphine HCL industry policy and plan, Nalbuphine HCL product specification, manufacturing process,......
  • 2014 Deep Research Report on Global and China Naltrexone HCL Industry
    Published: 28-Oct-2014        Price: US $2200 Onwards        Pages: 138
    This is a professional and depth research report on Global Naltrexone HCL industry. The report firstly introduced Naltrexone HCL basic information included Naltrexone HCL definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis. Global Regional (such as US Europe Asia China Japan etc regions) Global Leading Suppliers, different type products, different applications etc Naltrexone HCL production and market shar......
  • PharmaLeaders: Global Pharmaceutical Market Benchmark Report – Retrospective and Forward-Looking Analysis of the Leading Pharmaceutical Companies
    Published: 27-Oct-2014        Price: US $3995 Onwards        Pages: 376
    The Global Pharmaceutical Market Benchmark Report applies GlobalData's proprietary ranking methodology to compare the competitive positions of 30 leading drug companies on 25 financial metrics. These companies are analyzed based on financial performance, cost-containment, capital structure, and firm utilization to illustrate the different strategies these companies are using to increase value for their shareholders and create a competitive advantage. Throughout the report, GlobalData's Industry ......
  • EpiCast Report: Irritable Bowel Syndrome – Epidemiology Forecast to 2023
    Published: 27-Oct-2014        Price: US $3995 Onwards        Pages: 49
    Irritable Bowel Syndrome (IBS) is a chronic, relapsing gastrointestinal disorder that is characterized by abdominal discomfort or pain, bloating, and changes in bowel habit. Due to the lack of a demonstrable structural abnormality to explain these symptoms, IBS is classified as a functional gastrointestinal disorder. IBS is one of the most common gastrointestinal disorders; moreover, it has a significant negative impact on a patient's quality of life and social functioning. That said, IBS is ......
  • EpiCast Report: Cushing’s Syndrome – Epidemiology Forecast to 2023
    Published: 27-Oct-2014        Price: US $3995 Onwards        Pages: 58
    Cushing's syndrome (CS) is a rare disorder caused by prolonged exposure to excess amounts of circulating free glucocorticoids, such as cortisol. Cortisol is a hormone produced by the adrenal glands that has many functions in the body, such as anti-inflammatory action, antiallergic action, antianabolic action, and amino acid catabolic action. CS is associated with increased mortality caused by complications due to excess cortisol. GlobalData epidemiologists forecast an increase in the diagnose......
  • Hormone-Sensitive Prostate Cancer – Pipeline Review, H2 2014
    Published: 25-Oct-2014        Price: US $2000 Onwards        Pages: 36
    Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014', provides an overview of the Hormone-Sensitive Prostate Cancer's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hormone-Sensitive Prostate Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of admin......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs